Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis

Clin Exp Immunol. 2018 Apr;192(1):7-17. doi: 10.1111/cei.13086. Epub 2017 Dec 26.

Abstract

A new procedure was developed and applied to study immunoglobulin free light chains (FLC) in saliva of healthy subjects and patients with multiple sclerosis (MS). The procedure was based on a Western blot analysis for detection and semiquantitative evaluation of monomeric and dimeric FLCs. The FLC indices accounting for the total FLC levels and for the monomer/dimer ratios of κ and λ FLC were calculated, and the cut-off values of the FLC indices were determined to distinguish healthy state from MS disease. The obtained FLC index values were statistically different in the saliva of three groups: active MS patients, MS patients in remission and healthy subjects groups. Our FLC monomer-dimer analysis allowed differentiation between healthy state and active MS with specificity of 100% and a sensitivity of 88·5%. The developed technique may serve as a new non-invasive complementary tool to evaluate the disease state by differentiating active MS from remission with sensitivity of 89% and specificity of 80%.

Keywords: dimers; immunoglobulin free light chains; monomers; multiple sclerosis; saliva.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / analysis*
  • Blotting, Western / methods
  • Female
  • Humans
  • Immunoglobulin Light Chains / analysis*
  • Immunoglobulin kappa-Chains / analysis
  • Immunoglobulin lambda-Chains / analysis
  • Male
  • Middle Aged
  • Multiple Sclerosis / diagnosis*
  • Saliva / chemistry*
  • Sensitivity and Specificity

Substances

  • Biomarkers
  • Immunoglobulin Light Chains
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains